We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Daré Bioscience

News List

FDA Approves Xaciato (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis Drugs
December 09, 2021
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) approved Xaciato [zah-she-AH-toe] (clindamycin phosphate vaginal gel, 2%)...
Avomeen, Daré Partner to Accelerate Daré’s Pipeline contractpharma
September 03, 2020
Avomeen will provide contract development lab services to support the advancement of Daré’s investigational products in women’s health.
Daré Bioscience and Avomeen Form Partnership contractpharma
September 02, 2020
Accelerate the development of Daré’s pipeline of women’s health programs.